Is the Eutos Long Term Survival (ELTS) Score a Useful Marker to Predict Outcome in Children with Newly Diagnosed Chronic Myeloid Leukemia (CML) in Chronic Phase (CP)? the Experience of the International Registry of Childhood CML

被引：0

作者：

Millot, Frederic ^{[1
]}

De Keizer, Joe ^{[2
]}

Metzler, Markus ^{[3
]}

Suttorp, Meinolf ^{[4
]}

Sedlacek, Petr ^{[5
]}

Luesink, Maaike ^{[6
]}

Cheng, Frankie W. T. ^{[7
]}

Kalwak, Krzysztof ^{[8
,9
]}

Lausen, Birgitte ^{[10
]}

Jakovljevic, Gordana ^{[11
]}

De Moerloose, Barbara ^{[12
]}

Dworzak, Michael ^{[13
]}

Borisevich, Marina ^{[14
]}

Yajima, Julia ^{[15
]}

Ampatzidou, Mirella ^{[16
]}

Farah, Roula ^{[17
]}

Kaiserova, Emilia ^{[18
]}

Guenes, Adalet Meral ^{[19
]}

Baruchel, Andre ^{[20
]}

机构：

[1] CHU Poitiers, Inserm, CIC 1402, Poitiers, France

[2] Inserm, CIC 1402, Poitiers, France

[3] Univ Hosp Erlangen, Dept Pediat & Adolescent Med, Erlangen, Germany

[4] Tech Univ, Fac Med, Pediat Hematol & Oncol, Dresden, Germany

[5] Charles Univ Prague, Univ Hosp Motol, Dept Pediat Hematol Oncol, Prague, Czech Republic

[6] Princess Maxima Ctr Pediat Oncol, Dutch Childhood Oncol Grp, Utrecht, Netherlands

[7] Prince Wales Hosp, Dept Pediat, Hong Kong, Peoples R China

[8] Wroclaw Med Univ, Dept Pediat Hematol Oncol, Wroclaw, Poland

[9] Wroclaw Med Univ, BMT, Wroclaw, Poland

[10] Univ Copenhagen, Dept Pediat & Adolescent Med, Rigshosp, Copenhagen, Denmark

[11] Childrens Hosp, Dept Pediat Hematol Oncol, Zagreb, Croatia

[12] Ghent Univ Hosp, Dept Pediat Hematol Oncol, Ghent, Belgium

[13] St Anna Childrens Canc Res Inst, Vienna, Austria

[14] Belarusian Res Ctr Pediat Oncol Hematol & Immunol, Minsk, BELARUS

[15] Ctr Infantil Boldrini, Sao Paulo, Brazil

[16] Aghia Sophia Childrens Hosp, Dept Pediat Hematol Oncol, Athens, Greece

[17] LAU Med Ctr Rizk Hosp, Dept Pediat, Beirut, Lebanon

[18] Univ Childrens Hosp, Dept Pediat Oncol, Bratislava, Slovakia

[19] Hosp Gorukle, Pediat Hematol & Oncol, Bursa, Turkiye

[20] Robert Debre Hosp, Dept Pediat Hematol, Paris, France

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-173810

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

下载

页数：4

共 50 条

[41] Effect of Dose Modifications on 5-Year Efficacy of Dasatinib and Imatinib in Newly Diagnosed Patients with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP) From DASISION
Cortes, Jorge E.
Hochhaus, Andreas
Kantarjian, Hagop
Guilhot, Francois
Kota, Vamsi
Hughes, Timothy P.
Shelat, Suresh
Sy, Oumar
Jabbour, Elias
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 : S308 - S309
[42] Long term follow-up of frontline dasatinib in patients (pts) with early chronic phase chronic myeloid leukemia (CML-CP).
Maiti, Abhishek
Kantarjian, Hagop M.
Patel, Keyur
Borthakur, Gautam
Ravandi, Farhad
Verstovsek, Srdan
Ferrajoli, Alessandra
Estrov, Zeev
Kadia, Tapan M.
Skinner, Jeffrey A.
Poku, Rebecca A.
Dellasala, Sara
Luthra, Rajyalakshmi
Jabbour, Elias
Cortes, Jorge E.
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[43] EUTOS score is not predictive for survival and outcome in patients with early chronic phase chronic myeloid leukemia treated with tyrosine kinase inhibitors: a single institution experience
Jabbour, Elias
Cortes, Jorge
Nazha, Aziz
O'Brien, Susan
Quintas-Cardama, Alfonso
Pierce, Sherry
Garcia-Manero, Guillermo
Kantarjian, Hagop
BLOOD, 2012, 119 (19) : 4524 - 4526
[44] Nilotinib versus imatinib in patients (pts) with newly diagnosed chronic myeloid leukemia in chronic phase (CML-CP): ENESTnd 4-year (y) update
Larson, Richard A.
Hochhaus, Andreas
Saglio, Giuseppe
Kim, Dong-Wook
Jootar, Saengsuree
Le Coutre, Philipp D.
Reiffers, Josy
Pasquini, Ricardo
Goldberg, Stuart L.
Clark, Richard E.
Kemp, Charisse N.
Fan, Xiaolin
Menssen, Hans D.
Hughes, Timothy P.
Kantarjian, Hagop M.
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
[45] Early Optimization of Imatinib Therapy in Patients Newly Diagnosed with Chronic-Phase Chronic Myeloid Leukemia (CP-CML). A Study of the Spanish PETHEMA Group.
Cervantes, Francisco
Lopez-Garrido, Pilar
Montero, Maria-Isabel
Jonte, Femin
Martinez, Jesus
Hernan-dez-Boluda, Juan-Carlos
Calbacho, Maria
Sureda, Anna
Perez-Rus, Gloria
Nieto, Jose
Perez-Lopez, Cristina
Roman, Jose
Gonzalez, Marcos
Pereira, Arturo
Colomer, Dolors
BLOOD, 2009, 114 (22) : 456 - 457
[46] Dasatinib or imatinib (IM) in newly diagnosed chronic myeloid leukemia in chronic phase (CML-CP): Two-year follow-up from DASISION
Kantarjian, H.
Shah, N. P.
Cortes, J. E.
Baccarani, M.
Bradley-Garelik, M. B.
Zhu, C.
Hochhaus, A.
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
[47] Long-Term Follow-up of a Phase 1 Study of Ponatinib in Patients with Chronic-Phase Chronic Myeloid Leukemia (CP-CML)
Talpaz, Moshe
Cortes, Jorge E.
Kantarjian, Hagop
Shah, Neil P.
Bixby, Dale
Flinn, Ian
O'Hare, Thomas
Hu, Simin
Rivera, Victor M.
Clackson, Tim
Turner, Christopher D.
Haluska, Frank G.
Druker, Brian J.
Deininger, Michael W.
Mauro, Michael J.
BLOOD, 2014, 124 (21)
[48] Bosutinib (BOS) Versus Imatinib for Newly Diagnosed Chronic Phase (CP) Chronic Myeloid Leukemia (CML): Final 5-Year Results from the Bfore Trial
Brummendorf, Tim H.
Cortes, Jorge E.
Milojkovic, Dragana
Gambacorti-Passerini, Carlo
Clark, Richard E.
le Coutre, Philipp D.
Garcia-Gutierrez, Valentin
Chuah, Charles
Kota, Vamsi
Lipton, Jeffrey H.
Rousselot, Philippe
Mauro, Michael J.
Hochhaus, Andreas
Monroy, Rafael Hurtado
Leip, Eric
Purcell, Simon
Yver, Anne
Viqueira, Andrea
Deininger, Michael W.
BLOOD, 2020, 136
[49] Outcomes by cytogenetic and molecular response at 12 and 18 months of imatinib in patients with newly diagnosed chronic myeloid leukemia (CML) in chronic phase (CP) in the IRIS trial.
Baccarani, Michele
Guilhot, Francois
Larson, Richard A.
O'Brien, Stephen G.
Druker, Brian J.
BLOOD, 2006, 108 (11) : 606A - 606A
[50] Impact of dose reductions on 5-year efficacy in newly diagnosed patients with chronic myeloid leukemia in chronic phase (CML-CP) from DASISION.
Cortes, Jorge E.
Hochhaus, Andreas
Kantarjian, Hagop M.
Guilhot, Francois
Kota, Vamsi K.
Hughes, Timothy P.
Shelat, Suresh
Li, Li
Jabbour, Elias
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35

← 1 2 3 4 5 →